Aspirin and Isosorbide Dinitrate Combination Therapy for Cardiovascular Disease Management

Clinical Applications and Guidelines

• The American College of Cardiology recommends aspirin for prevention of ischemic events in patients with cardiovascular disease, and isosorbide dinitrate is commonly used for angina management 1, 2, 3
• The combination of aspirin and isosorbide dinitrate is beneficial in patients with history of myocardial infarction requiring both antiplatelet and vasodilatory therapy, and in patients with coronary artery disease with risk of thrombotic events 3, 4
• The American College of Cardiology/American Heart Association guidelines support the use of aspirin alongside other cardiovascular medications, including nitrates, in appropriate clinical scenarios 5, 6

Evidence and Efficacy

• Clinical studies have shown that aspirin can be safely used with other cardiovascular medications, including ACE inhibitors, with a composite risk reduction of 20% for patients taking aspirin with ACE inhibitors and 29% for those not taking aspirin 5, 6
• Aspirin and isosorbide dinitrate may be indicated for patients with TIA or stroke who also have angina, with typical antiplatelet doses of aspirin ranging from 75-325 mg daily 2, 7

Safety and Precautions

• There is an increased bleeding risk with aspirin, especially in patients with bleeding disorders or those on other anticoagulants 8
• Aspirin can be safely used with other cardiovascular medications, including ACE inhibitors, without significant adverse interactions 5, 6